Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia. [electronic resource]
Producer: 20170807Description: 4323-4328 p. digitalISSN:- 1527-7755
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- diagnosis
- Male
- Medicare -- economics
- Patient Compliance -- statistics & numerical data
- Prognosis
- Proportional Hazards Models
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Retrospective Studies
- Risk Assessment
- SEER Program
- Survival Rate
- Treatment Outcome
- United States
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.